MRK ▾TradingViewOVTLYR consoleNews (1w)Earnings search — Merck & Co., Inc.

Healthcare · ETF XLV · as of 2026-09-18

Daily · EMA 10 / 20 / 50 · SMA 200 · VolPress: buy/sell split, 20-SMA, white dot = above avg · · E = earnings · RS vs SPY ⓘ · ● RS new high ⓘ
MRK
Merck & Co., Inc. NYQ
Healthcare · Drug Manufacturers - General

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as liv...

Market cap
315.2B
P/E (TTM)
-
EPS (TTM)
-
Employees
75,000
IPO
1949-04-20
Website
merck.com

Price & today

$146.87 ATR(14) 3.32 (2.26%)
Stock today-0.19%
Sector ETF today-0.25%
Residual (stock-specific)+0.06%

Sector correlation

20-day correlation with XLV0.70
60-day correlation with XLV0.73
Status normal

Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.

Technicals

10 EMA$146.41
20 EMA$145.66
50 EMA$139.42
EMA stackBULLISH
RSI(14)55.4
52-week high distance+17.36%
52-week low distance+100.34%

Signals

Market F&G46.9
Bull%12.2%
OVTLYR status SELL (6d)
Sector rank#540
Next earnings 2026-10-29 (TNS, 40d)
TradingView OVTLYR console More news (Google) Sector dashboard (XLV)

MarketSmith metrics - our compute

RS Rating
86.0
ADR%
2.0
RMV (tight)
0.0
Ext (ATR>20EMA)
0.4
Rel Vol
309.0%
U/D 50d
1.12
U/D 25d
0.82
Accum/Dist 25d
4 / 5
EPS YoY
-106.0%
LoD dist
34.0
Off 52w High
6.4%
Above 52w Low
89.3%
1W / 1M
+2.0 / -3.5
Avg $Vol 50d
1.41B
Mkt Cap (B)
362.7
Trend 8/8
YES
Leads Group
YES
Sector XLV
+1.8% 1W
Base len (VCP)
13wk (5/29)
Coil (base shape)
85TVPX COIL
not available: float_shares(NULL->no Float%)
What do these abbreviations mean?
RS Rating
- IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
ADR%
- average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
RMV (tight)
- Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
Ext (ATR>20EMA)
- how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
Rel Vol
- latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
U/D 50d / 25d
- up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
Accum/Dist 25d
- heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
LoD dist
- close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
Off/Above 52w
- trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
Trend 8/8
- all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
Base len (VCP)
- weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.

Fundamentals & valuation - reference, not entry inputs

P/E (TTM)
-
Fwd P/E
-
PEG
-
Price/Book
-
Profit margin
-
ROE
-
Debt/Equity
-
Rev growth
-
Analyst target
$135 (-8%)
Analyst rating
BUY
Institutional %
79.3%
Insider %
-
Float %
-
Valuation and analyst figures are Yahoo company stats (weekly refresh, ~3,000 larger names - blanks are honest gaps); logo, employees, website and IPO date are Massive company reference. Momentum/VCP entries do not use valuation - this card is context so you do not have to leave the page.

Company data - context read, not entry inputs

Industry rank
4 / 147
Industry
Drug Manufacturers - General
Float
-
Float turnover 20d
-
Avg $Vol 20d / 50d
1.58B / 1.41B
Days to cover
-
Short % float
-
Institutional %
79.3%
Weinstein stage
2
Float, short interest and institutional % come from Yahoo company stats, refreshed weekly for ~3,000 larger names - a blank means Yahoo does not publish the figure for this stock, not that it is zero. Dollar volume and float turnover are computed from our own price bars; industry rank from our rotation data; stage from the weekly chart.

Quarterly EPS - earnings acceleration

A dash in %Chg is deliberate: the year-ago figure was a loss, so a growth % would be meaningless. A dash in Sales means we have no revenue figure for that quarter - read it as a gap in our data, not as zero revenue.

QuarterEPS ($)%Chg YoYSales ($M)%Chg
Oct-24 1.57 -26% 16,657.0 +4%
Feb-25 1.72 - 15,624.0 +7%
Apr-25 2.22 +7% 15,529.0 -2%
Jul-25 2.13 -7% 15,806.0 -2%
Oct-25 2.58 +64% 17,276.0 +4%
Feb-26 2.04 +19% 16,400.0 +5%
Apr-26 -1.28 -158% 16,286.0 +5%
Aug-26 -0.13 -106% 16,607.0 +5%
† = SEC carries this same fiscal quarter under a second period-end with a materially different figure (hover for it) - a restatement, merger recast or successor-period split; %Chg is blanked when the two are more than 15% apart. It fires only when the two period-ends DISAGREE, so it is a floor, not a guarantee that the rest of the column shares one basis · ‡ = the revenue concept changed from the previous quarter WITH A FIGURE (hover for both) - a blank row in between is skipped, as the eye does - a step at that row is a change of basis, not necessarily of business · EPS = Yahoo eps_actual (the figure MarketSmith/Deepvue show) - whether a given quarter is GAAP or excludes a one-off follows the filing, so it can sit either side of another vendor's number; AAPL's Oct-24 row, the Sep-2024 fiscal quarter, is $0.97 here - GAAP, including the EU tax charge - where TradingView's year implies $1.64 · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).

Recent news - our DB (Finnhub + OVTLYR)